COLOCALIZATION OF GROWTH-HORMONE [GH] AND GLYCOPROTEIN SUBUNIT-ALPHA IN GH-PRODUCING PITUITARY-ADENOMAS IN ACROMEGALIC PATIENTS

被引:0
|
作者
FURUHATA, S [1 ]
KAMEYA, T [1 ]
TSURUTA, T [1 ]
NARITAKA, H [1 ]
TOYA, S [1 ]
机构
[1] KEIO UNIV,SCH MED,DEPT NEUROSURG,TOKYO 160,JAPAN
关键词
ACROMEGALY; PITUITARY GLAND; GROWTH HORMONE; GONADOTROPIN ALPHA-SUBUNIT;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Thirty-one consecutive cases of pituitary adenoma in acromegalic patients were studied by immunohistochemistry. All adenomas contained cells immunoreactive with the anti-a-subunit of gonadotropic hormones (alpha; 0.6-53 % of tumor cells) as well as with,anti-growth hormone (GH; 4-74% of tumor cells). In serial section study, most cells immunoreactive with anti-a were identical to cells immunoreactive with anti-GH. There was a positive correlation between the percentages of cells immunoreactive for alpha in GH cells [alpha(%)/GH(%)] and those for prolactin (PRL) in immunoreactive tumor cells {PRL(%)/[PRL(%)+GH(%)]} in mixed GH cell-PRL cell adenomas, suggesting that the alpha-subunit may play a role in emergence of PRL cells. reported [1, 5-7, 9-16]. Furthermore, Beck-Peccoz et al. [1] and Osamura et al. [14] reported that a-subunit and GH coexisted in the same tumoral cells of some GH-producing adenomas. We examined pituitary adenomas of 31 consecutive acromegalic patients by immunohistochemistry focused on alpha. All the tumors of acromegalic patients were demonstrated to express alpha.
引用
收藏
页码:568 / 571
页数:4
相关论文
共 44 条
  • [41] Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting
    Micic, D
    Sumarac-Dumanovic, M
    Macut, D
    Kendereski, A
    Zoric, S
    Popovic, V
    Cvijovic, G
    Dieguez, C
    Casanueva, FF
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (04) : 333 - 340
  • [42] Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naïve to medical therapy and radiation: what to follow, GH or IGF-1 values?
    Jessica A. Brzana
    Chris G. Yedinak
    Johnny B. Delashaw
    Hume S. Gultelkin
    David Cook
    Maria Fleseriu
    Pituitary, 2012, 15 : 562 - 570
  • [43] Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess
    Wiesli, Peter
    Zwimpfer, Cornelia
    Zapf, Juergen
    Schmid, Christoph
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2006, 85 (08) : 900 - 905
  • [44] Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: Is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler, S.
    Tschopp, O.
    Sze, L.
    Neidert, M.
    Bernays, R. -L.
    Spanaus, K. -S.
    Wiesli, P.
    Schmid, C.
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2013, 188 : 282 - 287